CC
CERE

Corton Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Corton Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,693
Closed -$274K – 695
2024
Q2 		$274K Buy
+6,693
New +$279K 0.14% 229

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Corton Capital's CERE Position: Q3 2024 in Review

Corton Capital sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 6,693 shares — an estimated $274K sold.

Corton Capital first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $274K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Corton Capital reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Corton Capital sold 6,693 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $274K.
  • Corton Capital first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Corton Capital's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $274K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Corton Capital's 13F filing for Q3 2024, filed 14 Nov 2024.